Graner MW - Search Results

1

Marshall D, Mitchell DA, Graner MW, Bigner DD. Marshall D, et al. Among authors: graner mw. Handb Clin Neurol. 2012;104:309-30. doi: 10.1016/B978-0-444-52138-5.00020-7. Handb Clin Neurol. 2012. PMID: 22230450 Review. No abstract available.

2

Chaperone proteins and brain tumors: potential targets and possible therapeutics.

Graner MW, Bigner DD. Graner MW, et al. Neuro Oncol. 2005 Jul;7(3):260-78. doi: 10.1215/S1152851704001188. Neuro Oncol. 2005. PMID: 16053701 Free PMC article. Review.

3

Therapeutic aspects of chaperones/heat-shock proteins in neuro-oncology.

Graner MW, Bigner DD. Graner MW, et al. Expert Rev Anticancer Ther. 2006 May;6(5):679-95. doi: 10.1586/14737140.6.5.679. Expert Rev Anticancer Ther. 2006. PMID: 16759160 Review.

4

The heat shock response and chaperones/heat shock proteins in brain tumors: surface expression, release, and possible immune consequences.

Graner MW, Cumming RI, Bigner DD. Graner MW, et al. J Neurosci. 2007 Oct 17;27(42):11214-27. doi: 10.1523/JNEUROSCI.3588-07.2007. J Neurosci. 2007. PMID: 17942716 Free PMC article.

5

Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.

Everson RG, Graner MW, Gromeier M, Vredenburgh JJ, Desjardins A, Reardon DA, Friedman HS, Friedman AH, Bigner DD, Sampson JH. Everson RG, et al. Among authors: graner mw. Expert Rev Anticancer Ther. 2008 May;8(5):717-32. doi: 10.1586/14737140.8.5.717. Expert Rev Anticancer Ther. 2008. PMID: 18471045 Review.

6

Proteomic and immunologic analyses of brain tumor exosomes.

Graner MW, Alzate O, Dechkovskaia AM, Keene JD, Sampson JH, Mitchell DA, Bigner DD. Graner MW, et al. FASEB J. 2009 May;23(5):1541-57. doi: 10.1096/fj.08-122184. Epub 2008 Dec 24. FASEB J. 2009. PMID: 19109410 Free PMC article.

7

ZD6474, a novel tyrosine kinase inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor, inhibits tumor growth of multiple nervous system tumors.

Rich JN, Sathornsumetee S, Keir ST, Kieran MW, Laforme A, Kaipainen A, McLendon RE, Graner MW, Rasheed BK, Wang L, Reardon DA, Ryan AJ, Wheeler C, Dimery I, Bigner DD, Friedman HS. Rich JN, et al. Among authors: graner mw. Clin Cancer Res. 2005 Nov 15;11(22):8145-57. doi: 10.1158/1078-0432.CCR-05-0319. Clin Cancer Res. 2005. PMID: 16299247

8

Heat shock protein 70-binding protein 1 is highly expressed in high-grade gliomas, interacts with multiple heat shock protein 70 family members, and specifically binds brain tumor cell surfaces.

Graner MW, Raynes DA, Bigner DD, Guerriero V. Graner MW, et al. Cancer Sci. 2009 Oct;100(10):1870-9. doi: 10.1111/j.1349-7006.2009.01269.x. Epub 2009 Jul 1. Cancer Sci. 2009. PMID: 19659607 Free PMC article.

9

Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme.

Kuan CT, Wakiya K, Dowell JM, Herndon JE 2nd, Reardon DA, Graner MW, Riggins GJ, Wikstrand CJ, Bigner DD. Kuan CT, et al. Among authors: graner mw. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):1970-82. doi: 10.1158/1078-0432.CCR-05-2797. Clin Cancer Res. 2006. PMID: 16609006

10

Mutant epidermal growth factor receptor (EGFRvIII) contributes to head and neck cancer growth and resistance to EGFR targeting.

Sok JC, Coppelli FM, Thomas SM, Lango MN, Xi S, Hunt JL, Freilino ML, Graner MW, Wikstrand CJ, Bigner DD, Gooding WE, Furnari FB, Grandis JR. Sok JC, et al. Among authors: graner mw. Clin Cancer Res. 2006 Sep 1;12(17):5064-73. doi: 10.1158/1078-0432.CCR-06-0913. Clin Cancer Res. 2006. PMID: 16951222

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

97 results

Search Page